Last reviewed · How we verify
Moderate intensity statin
Moderate intensity statin is a Small molecule drug developed by Yonsei University. It is currently FDA-approved.
Moderate intensity statins are a type of small molecule medication used to treat conditions such as atherosclerosis, acute coronary syndrome, and dyslipidemias. They are studied in clinical trials for their effectiveness in minimizing stroke risk and improving adherence to medication.
At a glance
| Generic name | Moderate intensity statin |
|---|---|
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study) (NA)
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health (PHASE2, PHASE3)
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial (PHASE2)
- Combined Effects of Statins and Exercise on Training Sensitive Health Markers (NA)
- Optimal Antiplatelet and Lipid Therapy in ACS With DES: OPACT Trial (NA)
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia (PHASE1)
- Comparison of High and Moderate Intensity Statins in Achieving the Target LDL-C Level After Acute Coronary Syndrome (NA)
- Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Moderate intensity statin CI brief — competitive landscape report
- Moderate intensity statin updates RSS · CI watch RSS
- Yonsei University portfolio CI
Frequently asked questions about Moderate intensity statin
What is Moderate intensity statin?
Who makes Moderate intensity statin?
What development phase is Moderate intensity statin in?
Related
- Manufacturer: Yonsei University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing